4//SEC Filing
Sassi Nir 4
Accession 0001493152-21-018906
CIK 0001857044other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 5:00 PM ET
Size
5.4 KB
Accession
0001493152-21-018906
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-08-04+35,000→ 35,000 totalExercise: $8.87Exp: 2026-08-04→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable over a period of twelve months in four equal quarterly installments and accelerate upon termination of Mr. Sassi's consulting agreement with Indaptus Therapeutics, Inc.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001760673
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 5:00 PM ET
- Size
- 5.4 KB